Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 16 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/22/2007 First Published: 2/1/1999


1.		Phase II Study of Rebeccamycin Analogue in Children With Relapsed or Refractory Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				Children				NCI				MSKCC-98095 NCI-T98-0041, NCT00003737, T98-0041

Last Modified: 5/26/2003 First Published: 4/1/2000


2.		Phase II Study of Rebeccamycin Analogue in Patients With Advanced Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				WSU-C-2063 NCI-T99-0113, NCT00005027, T99-0113

Last Modified: 12/1/2002 First Published: 4/1/2000


3.		Phase II Study of Rebeccamycin Analogue in Patients With Metastatic or Locally Recurrent Colorectal Cancer (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				AECM-T99-0109 NCI-T99-0109, NCT00005085, T99-0109

Last Modified: 11/6/2006 First Published: 6/1/2000


4.		Phase II Randomized Study of Rebeccamycin Analogue in Women With Stage IIIB or IV Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				DFCI-99283 CWRU-DFCI-1199, NCI-197, NCT00005817, 197

Last Modified: 11/17/2005 First Published: 7/1/2000


5.		Phase II Study of Rebeccamycin Analogue in Patients With Advanced Hepatobiliary Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				CWRU-2299 NCI-96, NCT00005997, 96

Last Modified: 7/23/2003 First Published: 7/1/2000


6.		Phase II Randomized Study of Rebeccamycin Analogue Via 1 Infusion Versus 5 Daily Infusions in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				Not specified				NCI				CWRU-1599 NCI-91, NCT00006017, 91

Last Modified: 12/7/2007 First Published: 8/1/2000


7.		Phase II Study of Rebeccamycin Analogue in Children With Solid Tumors or Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				21 and under at original diagnosis				NCI				COG-P9963 P9963, NCT00006102

Last Modified: 11/1/2001 First Published: 9/1/2000


8.		Phase II Study of Rebeccamycin Analogue in Patients With Refractory Stage III or IV Ovarian Epithelial Cancer (Summary Last Modified 11/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				21 and over				NCI				NU-NCI-00G1 NCI-1132, NCT00006262, 1132

Last Modified: 10/1/2008 First Published: 5/28/2004


9.		Phase II Study of Rebeccamycin Analogue as Second-Line Therapy in Patients With Limited or Extensive Stage Small Cell Lung Cancer That Relapsed After Prior First-Line Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				CASE-CWRU-1503 NCI-1990, 1990, NCT00084487, CASE-1503

Last Modified: 6/1/2000


10.		Phase I Study of a Rebeccamycin Analogue in Patients With Metastatic Epithelial and Mesenchymal Tumors and Malignant Lymphomas (Summary Last Modified 06/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				WCCC-CO-9493 NCI-T94-0118H, T94-0118

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute